#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic myelomonocytic leukaemia Gastric cancer Peripheral T-cell lymphoma unspecified Transient ischaemic attack Congenital absence of bile ducts Heart disease congenital Juvenile chronic myelomonocytic leukaemia Intracranial germ cell tumour Colon cancer Intracranial calcification Cutaneous T-cell lymphoma refractory Renal cell carcinoma Stargardt's disease Neoplasm malignant Neovascular age-related macular degeneration More trials…

    Learn about Rare Diseases

    SAPHO syndrome – Basic Information Congenital nephrogenic diabetes insipidus – Trials in Disease Alexander disease – Basic Information Pemphigus Synovial sarcoma recurrent – Treatment Optic glioma – Treatment Haemophilia – Treatment Cystic fibrosis lung – Life with Disease Pituitary-dependent Cushing’s syndrome – Treatment Progressive supranuclear palsy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mosaic Hbcoreag Adrenaline Tartrate Ph. Eur. Clenbuterol Hydrochloride ROC-101 HYDROCHLORIDE Benzylpenicillin Sodium Brexpiprazole Fumarate Lisdexamfetamine Dimesylate Df1001 Cangrelor Tetrasodium Brexucabtagene Autoleucel Daunorubicin Ima203Cd8 HUMAN COAGULATION FACTOR XIII Solrikitug DROSPIRENONE Rp-1664 Sulfate Barium Sulfate Magnesium Chloride Bezafibrate Dog Epithelium Extract More therapies…

    Learn about Your Condition

    Necrotising myositis Urinary incontinence Breast cancer stage II Tachypnoea Diabetic foot Chondrosarcoma metastatic Appendicitis White matter lesion Erectile dysfunction Epstein-Barr virus infection Agitation Thrombolysis Alveolar proteinosis Piriformis syndrome Infant sedation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Apomorphine Hydrochloride and Sodium Chloride for Patients with Severe Brain Injury and Disorders of Consciousness

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • Apomorphine Hydrochloride Hemihydrate
    • Sodium Chloride
    Belgium Spain

  • Study on Pomalidomide for HIV Control in Patients on ART and During Treatment Interruption

    Recruiting

    1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Pomalidomide
    Denmark Spain

  • Study on Ibuprofen vs. Conventional Treatment for Patients with Acute Myocarditis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myocarditis
    Investigated Drugs:
    • Ibuprofen
    Spain

  • Study on the Safety and Effects of Pegunigalsidase Alfa for Children and Adolescents with Fabry Disease

    Recruiting

    4 1 1
    Investigated Drugs:
    • Pegunigalsidase Alfa
    Austria France Norway Spain

  • Study of Pioglitazone and Avelumab Combined with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients with Complete Cytogenetic Response

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Pioglitazone
    • Avelumab
    France

  • Study on the Effectiveness of Hormonal Treatment with Estradiol Hemihydrate and Testosterone in Adolescents with Gender Dysphoria

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Estradiol Hemihydrate
    • Testosterone
    France
Previous Page
1 … 370 371 372 373 374 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!